Southern Model Biology (688265.SH): The actual controller has renewed the concerted action agreement.

On December 27, Gelonghui reported that Nanmo Biological (688265.SH) announced the receipt of a notice from its actual controllers, Mr. Fei Jian and Mr. Wang Mingjun, regarding the renewal of the concerted action agreement set to expire. In view of the impending expiration of the concerted action agreement and its supplementary agreement signed prior to the company's initial public offering of Stocks, both parties have renewed the "Concerted Action Agreement (2024)" to ensure the continuity and stability of the company's Operation and to achieve substantive and effective control over the company.

Gelonghui FinanceDec 27, 2024 15:41

Express News | Summary of shareholding reductions of listed companies on December 11.

BreakingsDec 11, 2024 22:37

Express News | Nanmo Biological: Shareholder Kang Jun Ningyuan plans to reduce shareholding by no more than 1.90% of the company's shares.

BreakingsDec 11, 2024 18:36

Nanmo Biology: third quarter report 2024

SZSIOct 31, 2024 00:00 · Announcements

Third Quarter Report 2024

SZSIOct 31, 2024 00:00 · Announcements

The downstream encountered a cold impact on earnings. Nangmod Biological plans to increase production capacity utilization rate, with overseas as a "key expansion area". | Focus on the earnings conference

①Due to the unfavorable impact of downstream industrial clients' investment and financing, Namo Biotechnology's performance has been under continued pressure in recent years. Chairman Fei Jian revealed that the overall utilization rate of domestic production capacity is close to 80%, and will further improve the capacity utilization rate in the future; ②In the first half of 2024, the proportion of overseas business income has already increased to 14%. Fei Jian openly stated that overseas expansion is a key focus, and in the second half of the year, the overseas business development team will be further optimized.

cls.cnOct 10, 2024 17:09